CEDM as a Screening Tool for Breast Cancer in Higher-risk Women: A Prospective Study

NCT05797129 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 351

Last updated 2023-04-04

No results posted yet for this study

Summary

To evaluate the effectiveness of Contrast-enhanced digital mammography (CEDM) in detecting breast cancer in women at higher risk.

Conditions

Interventions

DEVICE

CEDM

Women underwent CEDM screening

Sponsors & Collaborators

  • Kaohsiung Veterans General Hospital.

    lead OTHER

Principal Investigators

  • Chen-Pin Chou, MD · Kaohsiung Veterans General Hospital.

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05797129 on ClinicalTrials.gov